Guide to the Application of Genotyping to Tuberculosis Prevention and Control

Tuberculosis Genotyping Case Studies: How TB Programs Have Used Genotyping

Genotyping Used to Improve Contact and Cluster Investigations

The Massachusetts Department of Public Health recently reported on their universal genotyping program and provided evidence that genotyping strengthened both their contact and cluster investigations (Miller 2002).

Table 2.1. Relationship or location of presumed transmission for 25 patients with suspected epidemiologic links detected during contact investigations that were not confirmed by subsequent genotyping results — Massachusetts, 1996–2000.

From 1996 through 2000, Massachusetts used routine contact investigations to identify 92 epidemiologic links between 984 persons with TB. Subsequent genotyping results with IS6110-based RFLP and spoligotyping confirmed that 67 (73%) of these had matching genotype patterns. In 25 (27%), however, the reported epidemiologic links were not supported by matching genotyping results. The reported relationships or locations of transmission that were revealed by genotyping to be misleading are shown in Table 2.1. In addition to identifying misleading epidemiologic links, the Massachusetts program used universal genotyping and subsequent cluster investigations to identify 21 patients who shared genotyping matches and epidemiologic links that were not found by routine contact investigations (Table 2.2). The settings of transmission for these unexpected epidemiologic links were often nontraditional, and at least one cluster consisting of three patients was the result of casual transmission. The routine contact investigations found nothing in common among the three, but the subsequent cluster investigation established that one patient had been the hairdresser of the second patient, who spent time in a college dormitory where the third patient was a security guard.

Table 2.2. Newly recognized transmission settings detected by cluster investigations, Massachusetts.

Last Reviewed: 05/18/2008
Content Source: Division of Tuberculosis Elimination
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

 
Back to Top of Page

If you would like to order any of the DTBE publications please visit the online order form.

You will need Adobe Acrobat™ Reader v5.0 or higher to read pages that are in PDF format.  Download the Adobe Acrobat™ Reader.

If you have difficulty accessing any material on the DTBE Web site because of a disability, please contact us in writing or via telephone and we will work with you to make the information available.

Division of Tuberculosis Elimination
Attn: Content Manager, DTBE Web site
Centers for Disease Control and Prevention
1600 Clifton Rd., NE Mailstop E-10
Atlanta, GA 30333
CDC-INFO at (1-800) 232-4636
TTY: 1 (888) 232-6348
E-mail: cdcinfo@cdc.gov

Home | Site Map | Contact Us
Accessibility | Privacy Policy Notice | FOIA | USA.gov
CDC Home | Search | Health Topics A-Z

Centers for Disease Control & Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Please send comments/suggestions/requests to: CDCINFO@cdc.gov